(Q44582053)

4 December 2017

Lack of inverse agonistic activity of nebivolol, its D- and L-enantiomers and of in vivo metabolized nebivolol in human myocardium (English)

1 reference

4 December 2017

1 reference

1 reference

Andreas Bundkirchen

1

1 reference

4 December 2017

Quang Nguyen

2

1 reference

4 December 2017

Klara Brixius

3

1 reference

4 December 2017

Birgit Bölck

4

1 reference

4 December 2017

Uwe Mehlhorn

5

1 reference

4 December 2017

Robert H G Schwinger

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Journal of Pharmacology

4 December 2017

1 reference

4 December 2017

476

1 reference

4 December 2017

1-2

1 reference

4 December 2017

97-105

1 reference

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Effect of beta-blockers on free radical-induced cardiac contractile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol is devoid of intrinsic sympathomimetic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Regulation of basal myocardial function by NO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Interaction of halothane with inhibitory G-proteins in the human myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Evidence against spare or uncoupled beta-adrenoceptors in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Force-frequency-relation in human atrial and ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

The failing human heart is unable to use the Frank-Starling mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Paracrine and autocrine effects of nitric oxide on myocardial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902116-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(03)02116-2

1 reference

4 December 2017

1 reference